Abstract
Recent studies suggest the presence of genetically distinct subtypes of attention deficit/hyperactivity disorder (ADHD) and that attention problems can be treated with receptor subtype selective nicotine agonists. In this study, individuals with two independent familial subtypes of ADHD defined by latent class analysis were systematically screened for sequence variations in the coding regions and intron/exon junctions of the nicotinic acetylcholine receptor alpha 4 subunit gene (CHRNA4). Common polymorphisms were used for transmission disequilibrium test (TDT) analyses. A significant association was found for a 5′ intron 2 single nucleotide polymorphism and severe inattention problems (P=0.007, effect size=4, 95% CI 1.3–14.1). The location of the polymorphism is compatible with it affecting pre-mRNA stability or splicing.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Todd RD, Rasmussen EK, Neuman RJ, Reich W, Hudziak JJ, Bucholz KK et al. Familiality and heritability of subtypes of ADHD in a population sample of female twins. Am J Psychiatry 2001; 158: 1891–1898.
Barkley RA . ADHD and the Nature of Self-Control. The Guilford Press: New York/London, 1997.
Todd RD . Genetics of attention deficit/hyperactivity disorder: are we ready for molecular genetic studies? Am J Med Genet (Neuropsychiatr Genet) 2000; 96: 241–243.
Todd RD, Botteron KN . Is attention deficit/hyperactivity disorder an energy deficiency syndrome? Biol Psychiatry 2001; 50: 151–158.
LaHoste GH, Swanson JM, Wigal SB, Glabe C, Wigal T, King N et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996; 1: 121–124.
Cook Jr EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56: 993–998.
Comings DE, Gade-Andavolu R, Gonzalez N, Wu S, Muhleman D, Blake H et al. Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder. Clin Genet 2000; 58: 31–40.
Daly G, Hawi Z, Fitzgerald M, Gill M . Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 1999; 4: 192–196.
Faraone SV, Doyle AE, Mick E, Biederman J . Meta-analysis of the association between the 7-repeat allele of the dopamine D4 receptor gene and attention deficit hyperactivity disorder. Am J Psychiatry 2001; 158: 1052–1057.
Grady S, Marks MJ, Wonnacott S, Collins AC . Characterization of nicotinic receptor-mediated [3H] dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 1992; 59: 848–856.
Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D, Meek WH et al. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacologia 1996; 123: 55–63.
Levin ED, Conners CK, Silva D, Hinton SC, Meek WH, March J et al. Transdermal nicotine effects on attention. Psychopharmacologia 1998; 140: 135–141.
Levin ED, Rezvani AH . Development of nicotinic drug therapy for cognitive disorders. Eur J Pharmacol 2000; 393: 141–146.
Levin ED, Conners CK, Silva D, Canu W, March J . Effects of chronic nicotine and methylphenidate in adults with attention deficit/hyperactivity disorder. Exp Clin Psychopharmacol 2001; 9: 83–90.
Mancuso G, Warburton DM, Melen M, Sherwood N, Tirelli E . Selective effects of nicotine on attentional processes. Psychopharmacology (Berl) 1999; 146: 199–204.
Grottick AJ, Higgins GA . Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task. Behav Brain Res 2000; 117: 197–208.
Wada E, Wada K, Boulter J, Deneris E, Heinemann S, Patrick J et al. Distribution of Alpha2, Alpha3, Alpha4, and Beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat. J Comp Neurol 1989; 284: 314–335.
Charpantier E, Barnéoud P, Moser P, Besnard F, Sgard F . Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area. Mol Neurosci 1998; 9: 3097–3101.
Hudziak JJ, Rudiger LP, Neale MC, Heath AC, Todd RD . A twin study of inattentive, aggressive and anxious/depressed behaviors. J Am Acad Child Adolesc Psychiatry 2000; 39: 469–476.
Reich W . Diagnostic interview for children and adolescents (DICA). J Am Acad Child Adolesc Psychiatry 2000; 39: 59–66.
Rasmussen ER, Neuman RJ, Heath AC, McStephen M, Hay DA, Levy F et al. Replication of the latent class structure of attention-deficit/hyperactivity disorder (ADHD) subtypes in a sample of Australian twins. J Child Psychol Psychiatry 2002; 43: 1018–1028.
Todd RD, Neuman RJ, Lobos EA, Jong E-JI, Reich W, Heath AC . Lack of association of dopamine D4 receptor gene polymorphisms with ADHD subtypes in a population sample of twins. Am J Med Genet (Neuropsychiatr Genet) 2001; 105: 432–438.
Todd RD, Jong YI, Lobos EA, Reich W, Heath AC, Neuman RJ . No association of the dopamine transporter gene 3′ VNTR polymorphism with ADHD subtypes in a population sample of twins. Am J Med Genet (Neuropsychiatr Genet) 2001; 105: 745–748.
Todd RD, Lobos EA . Mutation screening of the dopamine D2 receptor gene in attention deficit/hyperactivity disorder subtypes: preliminary report of a research strategy. Am J Med Genet (Neuropsychiatr Genet) 2002; 114: 34–41.
Sham PC, Curtis D . An extended transmission/disequilibrium test (TDT) for multiallele marker loci. Ann Hum Genet 1995; 59: 323–336.
Kent L, Middle F, Hawi Z, Fitzgerald M, Gill M, Feehan C et al. Nicotinic acetylcholine receptor alpha4 subunit gene polymorphism and attention deficit hyperactivity disorder. Psychiatr Genet 2001; 11: 37–40.
Wilens TE, Biederman J, Spencer T, Bostic J, Prince J, Monuteaux MC et al. A pilot controlled clinical trial of ABT-418 a cholinergic agonist in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry 1999; 12: 1931–1937.
Acknowledgements
This work was supported by NIH Grants MH52813 and NS 43762.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Todd, R., Lobos, E., Sun, LW. et al. Mutational analysis of the nicotinic acetylcholine receptor alpha 4 subunit gene in attention deficit/hyperactivity disorder: evidence for association of an intronic polymorphism with attention problems. Mol Psychiatry 8, 103–108 (2003). https://doi.org/10.1038/sj.mp.4001257
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001257
Keywords
This article is cited by
-
Exposure to fluoridated water and attention deficit hyperactivity disorder prevalence among children and adolescents in the United States: an ecological association
Environmental Health (2015)
-
Nicotinic acetylcholine receptors in attention circuitry: the role of layer VI neurons of prefrontal cortex
Cellular and Molecular Life Sciences (2014)
-
A randomized, double-blind, placebo-controlled crossover study of α4β2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder
Psychopharmacology (2014)
-
Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes
Human Genetics (2012)
-
Variation in the Nicotinic Acetylcholine Receptor Gene Cluster CHRNA5–CHRNA3–CHRNB4 and Its Interaction with Recent Tobacco Use Influence Cognitive Flexibility
Neuropsychopharmacology (2010)